NCT01761877 2023-02-10
NSAID Effects on Clinical and Imaging Breast Biomarkers
Stony Brook University
Phase 2 Completed
Clinical Trials
11 trialsNCT01483144 2021-06-08
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Phase 3 Completed
NCT00299195 2020-11-19
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00068419 2020-02-19
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Phase 2 Completed
NCT00841204 2017-12-26
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00392665 2017-04-13
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
Massachusetts General Hospital
Phase 2 Terminated
NCT00335504 2017-02-15
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01187901 2016-06-17
FAPEST
University of Utah
Phase 2 Completed
NCT01856322 2015-10-23
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00118365 2015-01-22
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
National Cancer Institute (NCI)
Phase 3 Completed
NCT00368927 2014-05-23
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed